| EIF2B1 |
EIF2B1, EIF2BA: Translation initiation factor eIF-2B subunit alpha |
NUP214 |
IPI00643352 |
0.263 |
Evidence |
|
| XPC |
XPC, XPCC: DNA-repair protein complementing XP-C cells |
SAMSN1 |
SAMSN1, HACS1: SAM domain-containing protein SAMSN-1 |
0.263 |
Evidence |
|
| STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
BRMS1 |
BRMS1: Breast cancer metastasis-suppressor 1 |
0.263 |
Evidence |
|
| EIF2B2 |
EIF2B2, EIF2BB: Translation initiation factor eIF-2B subunit beta |
HUWE1 |
HUWE1, KIAA0312, HSPC272, KIAA1578, UREB1: E3 ubiquitin-protein ligase HUWE1 |
0.263 |
Evidence |
|
| CRYBB2 |
CRYBB2, CRYB2, CRYB2A: Beta-crystallin B2 |
UNC84A |
IPI00401147 |
0.263 |
Evidence |
|
| SP100 |
IPI00011675 |
CFDP1 |
CFDP1, BCNT: Craniofacial development protein 1 |
0.263 |
Evidence |
|
| SAT |
SAT1, SAT: Diamine acetyltransferase 1 |
CFDP1 |
CFDP1, BCNT: Craniofacial development protein 1 |
0.263 |
Evidence |
|
| CSNK2A2 |
CSNK2A2, CK2A2: Casein kinase II subunit alpha' |
EZH2 |
EZH2: Enhancer of zeste homolog 2 |
0.263 |
Evidence |
|
| PRKAR2A |
PRKAR2A, PKR2, PRKAR2: cAMP-dependent protein kinase type II-alpha regulatory su |
SPA17 |
SPA17, SP17: Sperm surface protein Sp17 |
0.263 |
Evidence |
|
| CP110 |
IPI00478736 |
PDCD10 |
PDCD10, CCM3, TFAR15: Programmed cell death protein 10 |
0.263 |
Evidence |
|
| ARPC5 |
ARPC5, ARC16: Actin-related protein 2/3 complex subunit 5 |
DNASE1L3 |
DNASE1L3, DHP2, DNAS1L3: Deoxyribonuclease gamma precursor |
0.263 |
Evidence |
|
| SUPT5H |
SUPT5H, SPT5, SPT5H: Transcription elongation factor SPT5 |
C1orf82 |
RPAP2, C1orf82: RNA polymerase II-associated protein 2 |
0.263 |
Evidence |
|
| SUPT5H |
SUPT5H, SPT5, SPT5H: Transcription elongation factor SPT5 |
ASF1A |
ASF1A, CGI-98, HSPC146: Histone chaperone ASF1A |
0.263 |
Evidence |
|
| AP3B1 |
AP3B1, ADTB3A: AP-3 complex subunit beta-1 |
ARFIP1 |
IPI00216520 |
0.263 |
Evidence |
|
| STXBP3 |
STXBP3: Syntaxin-binding protein 3 |
NUP214 |
IPI00643352 |
0.263 |
Evidence |
|
| KPNA5 |
KPNA5: Importin subunit alpha-6 |
PCYT1B |
PCYT1B, CCTB: Choline-phosphate cytidylyltransferase B |
0.263 |
Evidence |
|
| NRGN |
NRGN: Neurogranin |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
0.263 |
Evidence |
|
| DARC |
DARC, FY, GPD: Duffy antigen/chemokine receptor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.263 |
Evidence |
|
| LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
DARC |
DARC, FY, GPD: Duffy antigen/chemokine receptor |
0.263 |
Evidence |
|
| CASP3 |
CASP3, CPP32: Caspase-3 precursor |
CNN1 |
CNN1: Calponin-1 |
0.263 |
Evidence |
|
| RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
RGS7 |
RGS7: Regulator of G-protein signaling 7 |
0.263 |
Evidence |
|
| CTNNA1 |
CTNNA1: Catenin alpha-1 |
LEF1 |
LEF1: Lymphoid enhancer-binding factor 1 |
0.263 |
Evidence |
|
| S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
MAP1B |
MAP1B: Microtubule-associated protein 1B |
0.263 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
PDE6G |
DKFZp686N1686, PDE6G, hCG_38056: Putative uncharacterized protein DKFZp686N1686 |
0.263 |
Evidence |
|
| CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
0.263 |
Evidence |
|